Zofran

(ondansetron) is a nausea drug manufactured by GlaxoSmithKline that was originally approved for use in individuals who were undergoing surgery or chemotherapy. GSK also hailed it as the most-prescribed pharmaceutical treatment for morning sickness, which they pushed to doctors in spite of being unapproved for expectant mothers. Families of children who suffered birth defects (mental, cleft lips and palates, club foot, skull deformities, heart defects, stomach and hearing problems)2 after mothers took Zofran while pregnant have sued GSK over allegations that it marketed the drug to pregnant women without FDA approval and failed to warn about risks. They also allege the company misrepresented the results of animal studies, claiming the studies showed the drug was safe when they actually showed abnormal bone growth and signs of toxicity. Read More…